Mavs coach Jason Kidd ejected shortly before Naji Marshall is tossed as well against Orlando

Dallas Mavericks coach Jason Kidd was ejected after just one technical foul and forward Naji Marshall was tossed moments ...

Rockets win their 5th straight, beating the Jazz 140-106 behind 25 points from Kevin Durant

Kevin Durant scored 25 points and the Houston Rockets won their fifth straight game by beating the Utah Jazz 140-106.
NFL

Jaguars sign pass rusher Travon Walker to four-year, $110 million contract extension

The Jacksonville Jaguars are signing pass rusher Travon Walker to a four-year, $110 million contract that includes $77 ...

After founding one unicorn company this AI pioneer is doing it again

After founding the "Google for LLMs," You.com, Richard Socher's next company, Recursive AI, could automate AI research itself ...
The Caledonian-Record

Recursion Announces Vicki Goodman, M.D., as Incoming Chief Medical Officer

Recursion (Nasdaq: RXRX), a leading clinical-stage TechBio company decoding biology to radically improve lives, today ...
Insider Monkey

Is Recursion Pharmaceuticals Inc. (RXRX) The Best Overlooked Penny Stock to Invest In?

Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) is among the overlooked penny stocks to invest in. On January 12, Alec Stranahan, an analyst at Bank of America Securities, maintained a Hold rating on ...
Reuters

Recursion Pharma's AI-powered therapy reduces polyp growth in a rare disease trial

Dec 8 (Reuters) - Recursion Pharma (RXRX.O), opens new tab, which uses artificial intelligence to discover new drug candidates, said on Monday its experimental oral drug helped reduce abnormal growths ...
The Harvard Crimson

Former Google CEO Eric Schmidt Warns AI Could Think For Itself In Four Years at Harvard Talk

Former Google CEO Eric E. Schmidt predicted that artificial intelligence will be able to learn from itself within four years at a forum hosted by the Harvard Kennedy School on Monday, where he issued ...
STAT

Recursion’s incoming CEO: Beyond hype on AI-driven drug development, it’s time to show results

Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.71. LONDON — In the year-plus since Najat Khan joined the AI-focused drug ...
Forbes

Recursion’s Incoming CEO Needs To Prove That AI Drug Development Can Pay Off

After a challenging 12 years trying to use AI to create new medicines, cofounder Chris Gibson stepped down as CEO last week. Can R&D chief and new CEO Najat Khan turn it around? In 2014, Recursion ...